Skip to main content

Table 1 Sample characteristics of the S-ketamine and the control group

From: A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

VariablesCategoriesS-ketamine groupControl group
Group size a 88
Gender aFemale45
Male43
Age b 52.13 ± 13.2554.63 ± 13.23
Diagnosis at admission aBreast cancer03
Cancer of unknown primary11
Cervical cancer11
Glioblastoma10
Colorectal cancer10
HIV10
Liver cancer01
Lung cancer20
Ovarian cancer01
Pancreatic cancer01
Prostate cancer10
Length of stay in SPCU (days) b 14.63 ± 7.6913.00 ± 3.42
Mode of discharge aHome04
Hospice31
Other clinic02
Died on the ward51
Points of measurement (days) bT15.63 ± 2.883.38 ± 1.06
 T28.00 ± 3.707.50 ± 2.45
 Z15.88 ± 2.903.38 ± 1.06
 Z26.88 ± 2.904.38 ± 1.06
STADI anxiety bT168.88 ± 11.0157.38 ± 13.38
 T255.63 ± 11.7357.50 ± 12.46
STADI depression bT166.38 ± 10.8859.25 ± 12.51
 T257.75 ± 12.7559.00 ± 13.40
STADI global bT168.38 ± 8.8059.38 ± 13.66
 T257.38 ± 11.8759.00 ± 13.27
Pain bZ13.88 ± 1.642.88 ± 2.10
 Z23.50 ± 1.772.75 ± 1.67
Restlessness/anxiety cZ11.00 (1.00–1.75)1.00 (0–1.75)
 Z21.00 (1.00–1.00)1.00 (0–1.75)
  1. a= n
  2. b= M ± SD
  3. c= Mdn (IQR)